重視進展期胃癌腹腔熱灌注化療的臨床應用_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 胡建昆 , 劉凱

四川大學華西醫院胃腸外科，胃癌研究室（成都 610041）;

Corresponding?author：

胡建昆, Email: hujkwch@126.com

Keywords：

DOI：

10.7507/1007-9424.202007067

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 胡建昆, 劉凱. 重視進展期胃癌腹腔熱灌注化療的臨床應用. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(8): 917-921. doi: 10.7507/1007-9424.202007067 Copy

1.	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
2.	Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
3.	徐惠綿, 王鑫. 我國胃癌診治臨床研究現狀與展望. 中華胃腸外科雜志, 2020, 23(2): 109-114.
4.	Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol, 2017, 39(7): 1010428317714626.
5.	Liang H. Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis. Transl Gastroenterol Hepatol, 2016, 1(62): 1-6.
6.	陳新華, 陳豪, 李國新, 等. 腹腔熱灌注化療預防局部進展期胃癌根治術后腹膜復發的研究進展. 中華胃腸外科雜志, 2018, 21(5): 593-599.
7.	陸維祺, 萬柳華, 鎖濤, 等. 我國進展期胃癌圍手術期行預防性腹腔熱灌注化療的研究進展. 中國腫瘤臨床, 2012, 39(22): 1750-1753.
8.	中國抗癌協會腹膜腫瘤專業委員會, 廣東省抗癌協會腫瘤熱療專業委員會. 中國腹腔熱灌注化療技術臨床應用專家共識(2019 版). 中華醫學雜志, 2020, 100(2): 89-96.
9.	Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol, 2010, 17(9): 2370-2377.
10.	Beeharry MK, Zhu ZL, Liu WT, et al. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer, 2019, 19(1): 932.
11.	Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase Ⅲ study. BMC Cancer, 2014, 14: 183.
12.	Roviello F, Caruso S, Neri A, et al. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol, 2013, 39(12): 1309-1316.
13.	Liu K, Chen XZ, Zhang WH, et al. "Four-Step Procedure" of laparoscopic exploration for gastric cancer in West China Hospital: a retrospective observational analysis from a high-volume institution in China. Surg Endosc, 2019, 33(5): 1674-1682.
14.	Li JH, Zhang SW, Liu J, et al. Review of clinical investigation on recurrence of gastric cancer following curative resection. Chin Med J (Engl), 2012, 125(8): 1479-1495.
15.	Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg, 2000, 87(2): 236-242.
16.	王洪波, 汪欣, 劉斯, 等. 進展期胃癌術后腹腔熱灌注化療的研究進展. 中國腫瘤臨床, 2019, 46(2): 99-102.
17.	Desiderio J, Chao J, Melstrom L, et al. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer, 2017, 79: 1-14.
18.	Mi DH, Li Z, Yang KH, et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperthermia, 2013, 29(2): 156-167.
19.	Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol, 2004, 5(4): 219-228.
20.	Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol, 2019, 37(23): 2028-2040.
21.	Garofalo A, Valle M, Garcia J, et al. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol, 2006, 32(6): 682-685.
22.	Muller M, Chérel M, Dupré PF, et al. Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study. Eur Surg Res, 2011, 46(3): 139-147.
23.	Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia, 2001, 17(1): 1-18.
24.	Zunino B, Rubio-Pati?o C, Villa E, et al. Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90. Oncogene, 2016, 35(2): 261-268.
25.	Pelz JO, Vetterlein M, Grimmig T, et al. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol, 2013, 20(4): 1105-1113.
26.	Didelot C, Lanneau D, Brunet M, et al. Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Curr Med Chem, 2007, 14(27): 2839-2847.
27.	Chiva LM, Gonzalez-Martin A. A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer. Gynecol Oncol, 2015, 136(1): 130-135.
28.	Mallory M, Gogineni E, Jones GC, et al. Therapeutic hyperthermia: The old, the new, and the upcoming. Crit Rev Oncol Hematol, 2016, 97: 56-64.
29.	趙春翔, 龔昭, 金太欣. 腹腔鏡胃癌根治術聯合術中腹腔溫熱化療預防腫瘤復發的研究. 腹腔鏡外科雜志, 2008, 13(6): 487-488.
30.	吳曉江, 賈永寧, 季加孚. 腹腔熱灌注化療在胃癌腹腔轉移治療中的價值. 中國實用外科雜志, 2015, 35(10): 1071-1075.
31.	丁文賢, 邢漢飛, 王篤杰, 等. 進展期胃癌術后早期腹腔內化療臨床研究. 中華實用診斷與治療雜志, 2011, 25(1): 94-95.
32.	Ferron G, Gesson-Paute A, Classe JM, et al. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study. Gynecol Oncol, 2005, 99(2): 358-361.
33.	Ba MC, Cui SZ, Lin SQ, et al. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World J Gastroenterol, 2010, 16(15): 1901-1907.
34.	Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer, 2001, 4(1): 27-33.
35.	Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer, 2015, 73(8): 2048-2052.
36.	陳小春, 潘凱, 張桂英, 等. 胃癌患者術中腹腔內溫熱灌注化療的臨床研究. 中華胃腸外科雜志, 2004, 7(2): 134-136.
37.	Kunisaki C, Shimada H, Akiyama H, et al. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology, 2006, 53(69): 473-478.

1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
2. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
3. 徐惠綿, 王鑫. 我國胃癌診治臨床研究現狀與展望. 中華胃腸外科雜志, 2020, 23(2): 109-114.
4. Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol, 2017, 39(7): 1010428317714626.
5. Liang H. Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis. Transl Gastroenterol Hepatol, 2016, 1(62): 1-6.
6. 陳新華, 陳豪, 李國新, 等. 腹腔熱灌注化療預防局部進展期胃癌根治術后腹膜復發的研究進展. 中華胃腸外科雜志, 2018, 21(5): 593-599.
7. 陸維祺, 萬柳華, 鎖濤, 等. 我國進展期胃癌圍手術期行預防性腹腔熱灌注化療的研究進展. 中國腫瘤臨床, 2012, 39(22): 1750-1753.
8. 中國抗癌協會腹膜腫瘤專業委員會, 廣東省抗癌協會腫瘤熱療專業委員會. 中國腹腔熱灌注化療技術臨床應用專家共識(2019 版). 中華醫學雜志, 2020, 100(2): 89-96.
9. Glehen O, Gilly FN, Arvieux C, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol, 2010, 17(9): 2370-2377.
10. Beeharry MK, Zhu ZL, Liu WT, et al. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer, 2019, 19(1): 932.
11. Glehen O, Passot G, Villeneuve L, et al. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase Ⅲ study. BMC Cancer, 2014, 14: 183.
12. Roviello F, Caruso S, Neri A, et al. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol, 2013, 39(12): 1309-1316.
13. Liu K, Chen XZ, Zhang WH, et al. "Four-Step Procedure" of laparoscopic exploration for gastric cancer in West China Hospital: a retrospective observational analysis from a high-volume institution in China. Surg Endosc, 2019, 33(5): 1674-1682.
14. Li JH, Zhang SW, Liu J, et al. Review of clinical investigation on recurrence of gastric cancer following curative resection. Chin Med J (Engl), 2012, 125(8): 1479-1495.
15. Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg, 2000, 87(2): 236-242.
16. 王洪波, 汪欣, 劉斯, 等. 進展期胃癌術后腹腔熱灌注化療的研究進展. 中國腫瘤臨床, 2019, 46(2): 99-102.
17. Desiderio J, Chao J, Melstrom L, et al. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer, 2017, 79: 1-14.
18. Mi DH, Li Z, Yang KH, et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials. Int J Hyperthermia, 2013, 29(2): 156-167.
19. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol, 2004, 5(4): 219-228.
20. Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol, 2019, 37(23): 2028-2040.
21. Garofalo A, Valle M, Garcia J, et al. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol, 2006, 32(6): 682-685.
22. Muller M, Chérel M, Dupré PF, et al. Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study. Eur Surg Res, 2011, 46(3): 139-147.
23. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia, 2001, 17(1): 1-18.
24. Zunino B, Rubio-Pati?o C, Villa E, et al. Hyperthermic intraperitoneal chemotherapy leads to an anticancer immune response via exposure of cell surface heat shock protein 90. Oncogene, 2016, 35(2): 261-268.
25. Pelz JO, Vetterlein M, Grimmig T, et al. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia. Ann Surg Oncol, 2013, 20(4): 1105-1113.
26. Didelot C, Lanneau D, Brunet M, et al. Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Curr Med Chem, 2007, 14(27): 2839-2847.
27. Chiva LM, Gonzalez-Martin A. A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer. Gynecol Oncol, 2015, 136(1): 130-135.
28. Mallory M, Gogineni E, Jones GC, et al. Therapeutic hyperthermia: The old, the new, and the upcoming. Crit Rev Oncol Hematol, 2016, 97: 56-64.
29. 趙春翔, 龔昭, 金太欣. 腹腔鏡胃癌根治術聯合術中腹腔溫熱化療預防腫瘤復發的研究. 腹腔鏡外科雜志, 2008, 13(6): 487-488.
30. 吳曉江, 賈永寧, 季加孚. 腹腔熱灌注化療在胃癌腹腔轉移治療中的價值. 中國實用外科雜志, 2015, 35(10): 1071-1075.
31. 丁文賢, 邢漢飛, 王篤杰, 等. 進展期胃癌術后早期腹腔內化療臨床研究. 中華實用診斷與治療雜志, 2011, 25(1): 94-95.
32. Ferron G, Gesson-Paute A, Classe JM, et al. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study. Gynecol Oncol, 2005, 99(2): 358-361.
33. Ba MC, Cui SZ, Lin SQ, et al. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World J Gastroenterol, 2010, 16(15): 1901-1907.
34. Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer, 2001, 4(1): 27-33.
35. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer, 2015, 73(8): 2048-2052.
36. 陳小春, 潘凱, 張桂英, 等. 胃癌患者術中腹腔內溫熱灌注化療的臨床研究. 中華胃腸外科雜志, 2004, 7(2): 134-136.
37. Kunisaki C, Shimada H, Akiyama H, et al. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology, 2006, 53(69): 473-478.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

重視進展期胃癌腹腔熱灌注化療的臨床應用

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content